These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 26364162)

  • 21. Integrative post-genome-wide association analysis of CDKN2A and TP53 SNPs and risk of esophageal adenocarcinoma.
    Buas MF; Levine DM; Makar KW; Utsugi H; Onstad L; Li X; Galipeau PC; Shaheen NJ; Hardie LJ; Romero Y; Bernstein L; Gammon MD; Casson AG; Bird NC; Risch HA; Ye W; Liu G; Corley DA; Blount PL; Fitzgerald RC; Whiteman DC; Wu AH; Reid BJ; Vaughan TL
    Carcinogenesis; 2014 Dec; 35(12):2740-7. PubMed ID: 25280564
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Constrained Score Statistics Identify Genetic Variants Interacting with Multiple Risk Factors in Barrett's Esophagus.
    Dai JY; Tapsoba Jde D; Buas MF; ; Risch HA; Vaughan TL
    Am J Hum Genet; 2016 Aug; 99(2):352-65. PubMed ID: 27486777
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Familiality in Barrett's esophagus, adenocarcinoma of the esophagus, and adenocarcinoma of the gastroesophageal junction.
    Chak A; Ochs-Balcom H; Falk G; Grady WM; Kinnard M; Willis JE; Elston R; Eng C
    Cancer Epidemiol Biomarkers Prev; 2006 Sep; 15(9):1668-73. PubMed ID: 16985029
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determining Risk of Barrett's Esophagus and Esophageal Adenocarcinoma Based on Epidemiologic Factors and Genetic Variants.
    Dong J; Buas MF; Gharahkhani P; Kendall BJ; Onstad L; Zhao S; Anderson LA; Wu AH; Ye W; Bird NC; Bernstein L; Chow WH; Gammon MD; Liu G; Caldas C; Pharoah PD; Risch HA; Iyer PG; Reid BJ; Hardie LJ; Lagergren J; Shaheen NJ; Corley DA; Fitzgerald RC; ; Whiteman DC; Vaughan TL; Thrift AP
    Gastroenterology; 2018 Apr; 154(5):1273-1281.e3. PubMed ID: 29247777
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Global DNA methylation patterns in Barrett's esophagus, dysplastic Barrett's, and esophageal adenocarcinoma are associated with BMI, gender, and tobacco use.
    Kaz AM; Wong CJ; Varadan V; Willis JE; Chak A; Grady WM
    Clin Epigenetics; 2016; 8():111. PubMed ID: 27795744
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The molecular signature of normal squamous esophageal epithelium identifies the presence of a field effect and can discriminate between patients with Barrett's esophagus and patients with Barrett's-associated adenocarcinoma.
    Brabender J; Marjoram P; Lord RV; Metzger R; Salonga D; Vallböhmer D; Schäfer H; Danenberg KD; Danenberg PV; Selaru FM; Baldus SE; Hölscher AH; Meltzer SJ; Schneider PM
    Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2113-7. PubMed ID: 16172218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Whole-genome sequencing provides new insights into the clonal architecture of Barrett's esophagus and esophageal adenocarcinoma.
    Ross-Innes CS; Becq J; Warren A; Cheetham RK; Northen H; O'Donovan M; Malhotra S; di Pietro M; Ivakhno S; He M; Weaver JMJ; Lynch AG; Kingsbury Z; Ross M; Humphray S; Bentley D; Fitzgerald RC
    Nat Genet; 2015 Sep; 47(9):1038-1046. PubMed ID: 26192915
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetics of Barrett's: the bigger, the better.
    El-Omar EM; Jankowski J
    Am J Gastroenterol; 2012 Sep; 107(9):1342-5. PubMed ID: 22951876
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aberrant methylation of secreted frizzled-related protein genes in esophageal adenocarcinoma and Barrett's esophagus.
    Zou H; Molina JR; Harrington JJ; Osborn NK; Klatt KK; Romero Y; Burgart LJ; Ahlquist DA
    Int J Cancer; 2005 Sep; 116(4):584-91. PubMed ID: 15825175
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prioritization and functional analysis of GWAS risk loci for Barrett's esophagus and esophageal adenocarcinoma.
    Chen J; Ali MW; Yan L; Dighe SG; Dai JY; Vaughan TL; Casey G; Buas MF
    Hum Mol Genet; 2022 Feb; 31(3):410-422. PubMed ID: 34505128
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determination of risk for Barrett's esophagus and esophageal adenocarcinoma.
    Thrift AP
    Curr Opin Gastroenterol; 2016 Jul; 32(4):319-24. PubMed ID: 27276368
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Germline variation in the insulin-like growth factor pathway and risk of Barrett's esophagus and esophageal adenocarcinoma.
    Dighe SG; Chen J; Yan L; He Q; Gharahkhani P; Onstad L; Levine DM; Palles C; Ye W; Gammon MD; Iyer PG; Anderson LA; Liu G; Wu AH; Dai JY; Chow WH; Risch HA; Lagergren J; Shaheen NJ; Bernstein L; Corley DA; Prenen H; deCaestecker J; MacDonald D; Moayyedi P; Barr H; Love SB; Chegwidden L; Attwood S; Watson P; Harrison R; Ott K; Moebus S; Venerito M; Lang H; Mayershofer R; Knapp M; Veits L; Gerges C; Weismüller J; Gockel I; Vashist Y; Nöthen MM; Izbicki JR; Manner H; Neuhaus H; Rösch T; Böhmer AC; Hölscher AH; Anders M; Pech O; Schumacher B; Schmidt C; Schmidt T; Noder T; Lorenz D; Vieth M; May A; Hess T; Kreuser N; Becker J; Ell C; Ambrosone CB; Moysich KB; MacGregor S; Tomlinson I; Whiteman DC; Jankowski J; Schumacher J; Vaughan TL; Madeleine MM; Hardie LJ; Buas MF
    Carcinogenesis; 2021 Apr; 42(3):369-377. PubMed ID: 33300568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic gastroesophageal reflux disease shares genetic background with esophageal adenocarcinoma and Barrett's esophagus.
    Gharahkhani P; Tung J; Hinds D; Mishra A; ; Vaughan TL; Whiteman DC; MacGregor S;
    Hum Mol Genet; 2016 Feb; 25(4):828-35. PubMed ID: 26704365
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gene expression profiling reveals stromal genes expressed in common between Barrett's esophagus and adenocarcinoma.
    Hao Y; Triadafilopoulos G; Sahbaie P; Young HS; Omary MB; Lowe AW
    Gastroenterology; 2006 Sep; 131(3):925-33. PubMed ID: 16952561
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polymorphisms near TBX5 and GDF7 are associated with increased risk for Barrett's esophagus.
    Palles C; Chegwidden L; Li X; Findlay JM; Farnham G; Castro Giner F; Peppelenbosch MP; Kovac M; Adams CL; Prenen H; Briggs S; Harrison R; Sanders S; MacDonald D; Haigh C; Tucker A; Love S; Nanji M; deCaestecker J; Ferry D; Rathbone B; Hapeshi J; Barr H; Moayyedi P; Watson P; Zietek B; Maroo N; Gay L; Underwood T; Boulter L; McMurtry H; Monk D; Patel P; Ragunath K; Al Dulaimi D; Murray I; Koss K; Veitch A; Trudgill N; Nwokolo C; Rembacken B; Atherfold P; Green E; Ang Y; Kuipers EJ; Chow W; Paterson S; Kadri S; Beales I; Grimley C; Mullins P; Beckett C; Farrant M; Dixon A; Kelly S; Johnson M; Wajed S; Dhar A; Sawyer E; Roylance R; Onstad L; Gammon MD; Corley DA; Shaheen NJ; Bird NC; Hardie LJ; Reid BJ; Ye W; Liu G; Romero Y; Bernstein L; Wu AH; Casson AG; Fitzgerald R; Whiteman DC; Risch HA; Levine DM; Vaughan TL; Verhaar AP; van den Brande J; Toxopeus EL; Spaander MC; Wijnhoven BP; van der Laan LJ; Krishnadath K; Wijmenga C; Trynka G; McManus R; Reynolds JV; O'Sullivan J; MacMathuna P; McGarrigle SA; Kelleher D; Vermeire S; Cleynen I; Bisschops R; Tomlinson I; Jankowski J
    Gastroenterology; 2015 Feb; 148(2):367-78. PubMed ID: 25447851
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene expression changes associated with Barrett's esophagus and Barrett's-associated adenocarcinoma cell lines after acid or bile salt exposure.
    Hao Y; Sood S; Triadafilopoulos G; Kim JH; Wang Z; Sahbaie P; Omary MB; Lowe AW
    BMC Gastroenterol; 2007 Jun; 7():24. PubMed ID: 17597535
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Temporal and spatial evolution of somatic chromosomal alterations: a case-cohort study of Barrett's esophagus.
    Li X; Galipeau PC; Paulson TG; Sanchez CA; Arnaudo J; Liu K; Sather CL; Kostadinov RL; Odze RD; Kuhner MK; Maley CC; Self SG; Vaughan TL; Blount PL; Reid BJ
    Cancer Prev Res (Phila); 2014 Jan; 7(1):114-27. PubMed ID: 24253313
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between markers of obesity and progression from Barrett's esophagus to esophageal adenocarcinoma.
    Duggan C; Onstad L; Hardikar S; Blount PL; Reid BJ; Vaughan TL
    Clin Gastroenterol Hepatol; 2013 Aug; 11(8):934-43. PubMed ID: 23466711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular targets for treatment of Barrett's esophagus.
    Feagins LA; Souza RF
    Dis Esophagus; 2005; 18(2):75-86. PubMed ID: 16053481
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gains and amplifications of c-myc, EGFR, and 20.q13 loci in the no dysplasia-dysplasia-adenocarcinoma sequence of Barrett's esophagus.
    Rygiel AM; Milano F; Ten Kate FJ; Schaap A; Wang KK; Peppelenbosch MP; Bergman JJ; Krishnadath KK
    Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1380-5. PubMed ID: 18559552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.